Wallner M, Kolesnik E, Ablasser K, Khafaga M, Wakula P, Ljubojevic S, Thon-Gutschi EM, Sourij H, Kapl M, Edmunds NJ, Kuzmiski JB, Griffith DA, Knez I, Pieske B, von Lewinski D (2015) Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium
"Peptides prepared to the highest standards are still untested experimental drugs," she said
RSC Chemical Biology
PubMed evidence trail For Cash Pay vs Insurance for GLP-1: Which Path Is Cheaper in 2025?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available
FDA Disclaimer: Medications referenced in this article, such as GLP-1 receptor agonists (semaglutide, tirzepatide), are FDA-approved for weight management and diabetes treatment but require a valid prescription